Ali Ertekin is an experienced Medical Manager with a strong history in the pharmaceuticals industry, specializing in cardiovascular metabolic health. After graduating from the Medical Faculty of 19 May University, they held various roles, including Medical Advisor at Novo Nordisk A/S and Eli Lilly and Company, where they were responsible for key areas such as diabetes and osteoporosis. Ali currently serves as the Executive Director - TA Medical Lead for Cardio Metabolic Health. Additionally, they have contributed as a Medical Consultant across several companies, showcasing a diverse skill set in healthcare services and marketing.
This person is not in any teams
This person is not in any offices